Elevation Point Wealth Partners LLC Has $483,000 Stock Position in Mettler-Toledo International, Inc. $MTD

Elevation Point Wealth Partners LLC grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 11.1% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 411 shares of the medical instruments supplier’s stock after buying an additional 41 shares during the quarter. Elevation Point Wealth Partners LLC’s holdings in Mettler-Toledo International were worth $483,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in Mettler-Toledo International by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock valued at $3,003,415,000 after acquiring an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares during the period. Geode Capital Management LLC boosted its position in shares of Mettler-Toledo International by 0.6% during the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after buying an additional 3,383 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after buying an additional 25,272 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Evercore ISI upped their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Robert W. Baird increased their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. JPMorgan Chase & Co. lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Stifel Nicolaus boosted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Finally, Barclays raised their price objective on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,406.50.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,476.72 on Friday. The company has a fifty day moving average price of $1,368.76 and a two-hundred day moving average price of $1,273.23. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,525.17. The stock has a market cap of $30.17 billion, a P/E ratio of 37.39, a P/E/G ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period in the prior year, the firm earned $10.21 EPS. Mettler-Toledo International’s quarterly revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Patrick Kaltenbach sold 2,000 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares in the company, valued at approximately $5,367,375. The trade was a 35.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 1,000 shares of the stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,990,168. This trade represents a 15.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 19,565 shares of company stock valued at $28,683,737. Insiders own 0.77% of the company’s stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.